Perkin Elmer
The FDA has made changes to how products containing sunscreen are labeled in the U.S. to ensure they meet the new regulations set forth for safety and effectiveness. The new regulations will require companies that want to use the "broad spectrum" label to test for both UVA and UVB protection. Previous regulations only dealt with preventing sunburn which is primarily due to UVB radiation but did not address UVA which protects against early ageing and skin cancer. All products that claim to provide broad spectrum SPF protection are regulated as sunscreen products. Therefore, the regulations the FDA has developed for over the counter (OTC) sunscreen products apply to cosmetics, moisturizers, lip balms and shampoos labeled with SPF values.
Table 1: Experimental Conditions.
Figure 1: All UVA and UVB compounds are eluted in a single run using a Brownlee SPP column with an optimized PerkinElmer HPLC system.
The methodology in Figure 1 provides one test method to determine both UVA and UVB compounds most commonly used in the sun care industry. Figure 2 is a sun care spray run with the same analytical conditions eluting six UVA/B compounds. All UVB and UVA compounds are eluted in a single run and can be quantitated in the ranges recommended by the FDA (SPF 15–50+). Only broad spectrum products with an SPF value of 15 or higher can claim to reduce the risk of skin cancer and early skin ageing if used as directed with other sun protection measures.
Figure 2: SPF 50 sun care spray shows elution of both UVA/B compounds.
(1) U.S. Food and Drug Administration, 2012. Information for Consumers, 2012. Retrieved from http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/ucm258468.htm.
PerkinElmer
940 Winter Street, Waltham, Massachusetts 02451, USA
tel. (800) 762 4000 fax (203) 944 4904
Website: www.perkinelmer.com
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.